Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
Titel:
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
Auteur:
Hamadani, Mehdi Collins, Graham P Caimi, Paolo F Samaniego, Felipe Spira, Alexander Davies, Andrew Radford, John Menne, Tobias Karnad, Anand Zain, Jasmine M Fields, Paul Havenith, Karin Cruz, Hans G He, Shui Boni, Joseph Feingold, Jay Wuerthner, Jens Horwitz, Steven